Robyn L. Schenk

Research Institute of Molecular Pathology

Also affiliated with Boehringer Ingelheim (Austria)

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer”.

SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer

Science Signaling(2025)10.1126/scisignal.aea2788

N/A

0DataRank · unranked

3 citations

Patricia L. Theard, Jacob M. Hughes, Bridget A. Finniff, Marco H. Hofmann, Kaja Kostyrko +6 more